Merck

Merck Named One of TIME’s 50 Genius Companies for Work in Ebola

Along with international agencies and governments, Merck has played — and continues to play — a leadership role in responding to Ebola.
Article

We’re honored to be in the top 50 for TIME's 2018 Genius Companies for our work in Ebola. We are inspired every day by the work we do to make an impact on global health.

Learn more about Merck's response to the Ebola outbreak.

Merck Named Number 4 on Equileap's List of World's Top Companies for Gender Equality

Multimedia with summary

Merck has been ranked in the 2018 Gender Equality Global Ranking by Equileap, making us one of the leading companies globally making progress towards gender equality in the workplace! 

To view Equipleap's full report, click here or learn more about Merck's commitment to diversity.

Merck Announces “Safer Childbirth Cities” Initiative, Issues Call to Action to Reverse the Rise in U.S. Maternal Deaths

Merck for Mothers Commits Additional $10M to Support Locally Created Solutions to Improve Maternal Health and Reduce Disparities
Press Release

KENILWORTH, N.J., October 3 , 2018 /3BL Media/ – Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today a new effort to support cities across the country to help women have a healthy pregnancy and safe childbirth. The “Safer Childbirth Cities” initiative is intended to reduce the number of maternal deaths and life-threatening childbirth events and narrow disparities in maternal health outcomes in the U.S.

Merck Emergency Drone Delivery Experiment Combines Supply Chain Innovation and Corporate Responsibility

Blog

A Merck experiment flying drones carrying medicines to remote locations to see if the technology is viable during emergencies may have appeal in disaster situations.

The pilot tests are innovative not just because they involve unmanned aerial vehicles but because of the technology-enabled, real-time, cold-chain monitoring systems on board. In simple terms, a device like a mobile phone sends data from the drone to the ground so engineers can monitor the temperature and therefore verify the stability of the medicines during the flight. 

Merck Ranked No. 2 in Fortune Magazine’s 2018 “Change the World” List

Article

Fortune magazine has released its latest "Change the World" list, a ranking of 57​ companies that are doing well by doing good. Merck ranked second on the list for our leadership role in the fight against Ebola, including our experimental Ebola vaccine and our support for humanitarian organizations involved in Ebola relief and recovery efforts.

Merck Foundation Supports New Programs to Improve Care for Alzheimer’s Patients and Caregivers in the United States

Press Release

KENILWORTH, N.J., August 15, 2018 /3BL Media/ -- The Merck Foundation (the Foundation) is supporting two new programs to improve the health and wellbeing of vulnerable individuals living with Alzheimer’s disease and their caregivers. With a focus on underserved rural and urban populations in New England and Minnesota, these programs are part of the Foundation’s $5 million effort to reduce disparities in health care for underserved communities affected by Alzheimer’s.

One Year Ago: CEOs Respond to Charlottesville

CECP looks back at the corporate response to Charlottesville
Blog

Today marks one year since Merck CEO Ken Frazier announced his resignation from the President's American Manufacturing Council in response to what he and his company felt was a failure to appropriately denounce "expressions of hatred, bigotry and group supremacy" on the part of the federal government.

Merck Reinforces Commitment to Responsible Pricing

Press Release

KENILWORTH, N.J., July 20, 2018 /3BL Media/ -- Merck (NYSE:MRK), known as MSD outside the United States and Canada, has a long history of responsible pricing. In 2017, Merck issued its second annual Pricing Action Transparency Report, which showed that net prices across Merck’s U.S. product portfolio declined by 1.9 percent. We believe that further changes are still necessary to help reduce patient out-of-pocket costs. To demonstrate our commitment to achieving this goal, we are making the following announcement:

Saving Mothers, Giving Life: Reflecting on Five Years of Partnership

by Dr. Mary-Ann Etiebet, Executive Director of Merck for Mothers
Blog

Five years ago, Saving Mothers, Giving Life (SMGL) – a major public-private partnership – set the ambitious goal of reducing maternal mortality by half in target districts in Uganda and Zambia, and later Nigeria.

More Than 300 Partners Want to Know – What Do Women and Girls Want Most When It Comes to Quality Health Care?

by Betsy McCallon, Chief Executive Officer, White Ribbon Alliance
Blog

Since our beginnings nearly 20 years ago, White Ribbon Alliance has brought diverse partners together to advance reproductive and maternal health and rights for women and girls. It’s always exciting to witness community, national and global partners bring their unique talents and resources together and realize a shared goal. The recently launched What Women Want campaign is especially motivating given its potential to transform accountability for reproductive and maternal health at the global and national levels.

Pages

Subscribe to Merck